Monsoon Causes Spurt In Hepatitis Cases In Capital
Doctors say the seasonal spike is linked to poor water quality, sanitation failures and unhygienic food practices, which put children, pregnant women and those with pre-existing liver disease at serious risk.
Several city hospitals reported a 30–40% increase in cases of acute viral hepatitis compared with the dry months. There was also a noticeable rise in outpatient visits for jaundice, abdominal pain, vomiting and other classic symptoms associated with hepatitis A and E.
"In the last three weeks, we saw a 40% surge in acute viral hepatitis in our OPD," said Dr Abhideep Chaudhary, president-elect, Liver Transplantation Society of India (LTSI), and vice-chairman, HPB and liver transplantation, BLK-Max Hospital.
"Most patients are unaware of hepatitis vaccination. Unsafe water and lack of awareness remain key triggers. Hepatitis E can be fatal during pregnancy, while hepatitis A can cause acute liver failure requiring, in some cases, a transplant."
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
No annual fees for life
UnionBank Credit Card
Apply Now
Undo
Monsoon problems such as waterlogging, sewage contamination, and open drains further accelerate the spread of hepatitis A and E viruses, particularly in urban slums and informal settlements.
You Can Also Check:
Delhi AQI
|
Weather in Delhi
|
Bank Holidays in Delhi
|
Public Holidays in Delhi
According to LTSI estimates and hospital data, over 70% of cases in India during the monsoon involve hepatitis E. Meanwhile, hepatitis A remains highly prevalent among children under 15. "This is a seasonal epidemic that returns every year, yet preparedness is lacking," rued Dr Sanjiv Saigal, president, LTSI.
"Infection is entirely preventable through clean water, hygienic food handling and vaccination for high-risk groups.
As we mark World Hepatitis Day, the focus must shift from treatment to prevention."
The World Health Organization estimates that hepatitis E causes nearly 20 million infections globally each year, with a significant proportion reported from India. In urban areas like Delhi, aging water infrastructure, unregulated street food vendors and rapid urbanisation fuel such outbreaks annually.
Chaudhary added that misinformation around jaundice being "self-limiting" often led to delayed diagnosis and worsened outcomes. "Patients believe they'll recover without treatment. By then, complications will have set in," he warned.
As part of World Hepatitis Day initiatives, NGOs and public health groups are stepping up awareness campaigns in flood-prone and high-risk zones — organising health camps, distributing leaflets and advocating improved sanitation in vulnerable areas.
"Our advice is simple: eat only well-cooked food, drink safe water and regularly wash hands with soap," said Dr Monika Jain, director, liver diseases and GI sciences, Sri Balaji Action Medical Institute.
While hepatitis B and C often dominate public discourse due to their long-term effects, doctors stress that hepatitis A and E pose an equally urgent threat during the monsoon season. Symptoms such as fatigue, nausea, dark urine and yellowing of the eyes are often ignored until the infection has progressed dangerously.
On World Hepatitis Day, doctors said the fight must begin with clean water, public hygiene, food safety and early intervention. These illnesses needn't be deadly because they're preventable.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
18 minutes ago
- Time of India
Cancer cure? Russia commences human trials of revolutionary personalized cancer vaccine
In a landmark advancement for oncology and personalized medicine, Russia's Gamaleya National Research Center of Epidemiology and Microbiology—the creators of the Sputnik V COVID-19 vaccine—announced this year that it will begin human clinical trials of the world's first personalized mRNA-based melanoma vaccine within the next few months. Alexander Gintsburg, director of the Gamaleya Center, confirmed that this groundbreaking vaccine, tailored specifically to the genetic profile of individual patients' tumors, will start experimental administration as early as September-October 2025 in collaboration with leading Russian oncology institutions . Explore courses from Top Institutes in Please select course: Select a Course Category Cybersecurity CXO others Public Policy Healthcare Digital Marketing Degree MBA Artificial Intelligence Others PGDM Data Science Data Analytics Product Management MCA Operations Management Leadership Design Thinking Project Management Finance Management healthcare Technology Data Science Skills you'll gain: Duration: 10 Months MIT xPRO CERT-MIT xPRO PGC in Cybersecurity Starts on undefined Get Details Q. What are melanoma cells by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 15 most beautiful women in the world Undo A. Melanoma cells come from melanocytes, the skin cells that give it color. When these cells grow too much and become cancerous, they cause melanoma, a dangerous kind of skin cancer that can spread fast if not treated early. Q. What is mRNA, and how is it used in vaccines? A. mRNA, or messenger RNA, is a molecule that carries genetic instructions from DNA to the cell's protein-making machinery. It acts like a messenger, conveying the code needed to build specific proteins that perform various functions in the body. In vaccines, mRNA teaches cells to produce a harmless piece of a virus or cancer antigen, triggering the immune system to respond and protect the body. Live Events This novel cancer vaccine is designed to train the immune system to recognize and attack melanoma cells by creating a bespoke mRNA blueprint derived from each patient's unique tumor mutations. The process involves sophisticated artificial intelligence algorithms that analyze the tumor's genetic data to produce a molecular template, which is then synthesized at Gamaleya's production facilities. This tailor-made mRNA encodes proteins that activate a targeted cytotoxic immune response, aiming not only to eradicate primary tumors but also to address metastatic cancer sites. Gintsburg elaborated that the entire vaccine development cycle—from tumor sequencing to vaccine production—can be completed within about one week due to AI-assisted mathematical modeling and neural network computing. This rapid manufacture represents a significant leap compared to typical timelines in personalized cancer therapies. Q. What is a personalized cancer vaccine? A. Personalized cancer vaccine is a tailored immunotherapy designed to train the patient's immune system to recognize and attack their specific cancer cells. It uses information from the patient's tumor genetics to create a unique vaccine that targets tumor-specific mutations, differing from general vaccines. The vaccine model was developed starting in mid-2022 and has already demonstrated promising efficacy in preclinical animal studies, showing the ability to suppress tumor growth and reduce metastasis. The upcoming Phase I clinical trials will take place at two of Russia's foremost oncology centers: the Hertsen Research Institute and the N.N. Blokhin National Medical Research Center of Oncology in Moscow. Importantly, this tailored vaccine is part of a wider Russian initiative to advance cancer treatment across various difficult-to-treat types, including pancreatic, kidney, and non-small-cell lung cancers. The Russian Ministry of Health classifies this vaccine development and approval under a new, specialized regulatory process recognizing its individualized nature, differing fundamentally from traditional drug registration. The state plans to provide this cancer vaccine free of charge to Russian citizens, with an estimated production cost of around 300,000 rubles (approx. USD 2,869) per dose covered by government funding. According to health authorities, about 4 million Russians live with cancer, and approximately 625,000 new cancer cases are diagnosed annually, underlining the urgent need for innovative therapies. The vaccine's success could mark a pivotal moment in Russia's fight against cancer and elevate its personalized medicine program. Unlike the COVID-19 mRNA vaccines designed to target a single viral antigen, this personalized cancer vaccine encodes multiple neoantigens specific to each patient's tumor, offering a multi-targeted immune approach.
Time of India
2 hours ago
- Time of India
After SC judgment, mental well being no longer charity but constitutional right: Experts
KOLKATA: Mental health activists and experts have welcomed the Supreme Court's explicit recognition of mental health as an integral part of the constitutional Right to Life under Article 21. They say this broadens the interpretation of the right to life to include psychological well-being, not just physical survival. The Supreme Court recognised the right to mental health as an integral component of the right to life under Article 21 while laying down binding guidelines for educational institutions and coaching centres across India. The observation was made in a case related to the death of a 17-year-old student undergoing coaching for the National Eligibility-cum Entrance Test (NEET) examination. The apex court set aside orders of the Andhra Pradesh High Court to allow the transfer of the investigation into the death under suspicious circumstances to the Central Bureau of Investigation (CBI). You Can Also Check: Kolkata AQI | Weather in Kolkata | Bank Holidays in Kolkata | Public Holidays in Kolkata Mental health activist Ratnaboli Ray, who is the founder of Anjali, a rights-based organisation, said the apex court order moves mental health from the realm of welfare or charity into the domain of legal and constitutional rights. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Health: the best shoes to walk and stand all day Ultra-Comfortable Shoes Undo "This means that the state and institutions are no longer simply encouraged but obligated to ensure mental health protections as part of their duty under the Constitution," said Ray, a psychologist by training. Ray also pointed out that by issuing guidelines for students' welfare in the context of mental health, the court has acknowledged the growing mental health crisis in educational spaces—ranging from anxiety and depression to suicide. This makes schools and universities potentially accountable for creating psychologically safe environments. "The court order represents a cultural shift. When the Supreme Court validates mental health as a constitutional concern, it plays a critical role in destigmatising mental illness, legitimising lived experiences, and encouraging both care-seeking and policy action," she said. Advocate Arush Sengupta pointed out that embedding mental health under Article 21 makes it justiciable. "If someone's right to mental well-being is violated—for example, through institutional neglect, discrimination, or lack of access to care—they can now take legal recourse based on constitutional grounds. This also strengthens the implementation of the Mental Healthcare Act, 2017, which already defines access to mental health services as a right, but until now lacked the direct constitutional force to ensure consistent and widespread enforcement," he said. Psychiatrist Aniruddha Deb felt the ruling has the potential to transform institutional accountability, public funding, and societal attitudes in India. "This is a landmark judgment. Till now, mental illness was perceived as a disability, a dysfunction and looked down upon. Treatment and care were neglected as were rights. People with mental illness were relegated to second-class citizens. They were even denied the right to vote. Being of unsound mind precluded them from holding any office. All that will change now. The moment you equate the right to mental health with the right to life, the whole observation changes," said Deb. Ray added that the moment demands bold, rights-affirming governance, not piecemeal or tokenistic gestures. "The judiciary has spoken. It is now the executive's responsibility to institutionalize this vision into everyday governance so that mental health is not only constitutionally protected, but meaningfully lived," she added. What SC judgment does * Broadens the interpretation of the right to life to include psychological well-being, not just physical survival * Moves mental health from the realm of welfare or charity into the domain of legal and constitutional rights. State and institutions are no longer simply encouraged but obligated to ensure mental health protections * Schools and universities potentially accountable for creating psychologically safe environments * Embedding mental health under Article 21 makes it justiciable. If someone's right to mental well-being is violated, they can now take legal recourse based on constitutional grounds * Strengthens the implementation of the Mental Healthcare Act, 2017, * To play a critical role in destigmatizing mental illness, legitimizing lived experiences, and encouraging care-seeking and policy action Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
Hindustan Times
3 hours ago
- Hindustan Times
Health Talk: Taking the road to hepatitis elimination
The International Agency for Research on Cancer (IARC) recently classified hepatitis D as carcinogenic—cancer-causing—to humans, just like hepatitis B and C. Hepatitis D, which only affects individuals infected with hepatitis B, is associated with a two- to six-fold higher risk of liver cancer compared to hepatitis B alone, it added. (AP/ Representative photo) Hepatitis D, which only affects individuals infected with hepatitis B, is associated with a two- to six-fold higher risk of liver cancer compared to hepatitis B alone, it added. Viral hepatitis – types A, B, C, D, and E – are major causes of acute liver infection. Among these, only hepatitis B, C, and D can lead to chronic infections that significantly increase the risk of cirrhosis, liver failure, or liver cancer. Each year, July 28 is observed as World Hepatitis Day, as viral hepatitis continues to remain a serious public health threat and one of the primary causes of liver cancer. Yet most people with hepatitis don't know they're infected, says the World Health Organization (WHO). According to the UN health body, types B, C, and D affect at least 300 million people globally and cause at least 1.3 million deaths each year, mainly from liver cirrhosis and cancer. In a paper published on Monday, The Lancet Commission also mentioned that three in five liver cancer cases happen due to preventable risk factors, including fatty liver, alcohol, and viral hepatitis. It also added that obesity-linked cancer cases are on the rise. The majority of liver cancer cases can be prevented by reducing levels of viral hepatitis, alcohol consumption, and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called non-alcoholic fatty liver disease), it said. Liver cancer is already a major cause of death and disability. Globally, it's the sixth most common cancer and the third leading cause of death from cancer. Interestingly, the Commission estimated in the paper that at least 60% of liver cancers are preventable via control of modifiable risk factors, including hepatitis B virus (HBV), hepatitis C virus (HCV), MASLD, and alcohol. While there are preventive measures and treatment available to combat this public health threat, last year's Global Hepatitis Report underscored some challenges that majorly impact disease management. According to the report, testing and treatment coverage remain critically low: only 13% of people with hepatitis B and 36% with hepatitis C had been diagnosed by 2022. Treatment rates were even lower – 3% for hepatitis B and 20% for hepatitis C – well below the 2025 targets of 60% diagnosed and 50% treated. Integration of hepatitis services remained uneven: 80 countries have incorporated hepatitis services into primary health care, 128 into HIV programmes, and just 27 have integrated hepatitis C services into harm reduction centres. The next challenge, according to the report, will be to scale up the implementation of prevention, testing, and treatment coverage. Achieving WHO's 2030 targets could save 2.8 million lives and prevent 9.8 million new infections. With declining donor support, countries must prioritize domestic investment, integrated services, better data, affordable medicines, and ending stigma, said experts in the report. 'Every 30 seconds, someone dies from a hepatitis-related severe liver disease or liver cancer. Yet we have the tools to stop hepatitis,' WHO director-general Tedros Adhanom Ghebreyesus said in a statement on World Hepatitis Day. He is right. We have the tools at our disposal; all we need is for stakeholders—governments, civil society, community leaders, etc.—to come together, to jointly work towards eliminating hepatitis.
